Effects of Clinical Pharmacist-Led Medication Management on Medication Adherence and Quality of Life in Stroke Patients Undergoing Intravenous Thrombolysis
Medical Science Monitor · 2026
DOI: 10.12659/msm.952042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2026. Verfasst von Jiali Niu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Jingjiang People's Hospital Affiliated to Yangzhou University, Jingjiang, Jiangsu, China. Hauptthemen laut MEDLINE: Pharmacists, Stroke, Thrombolytic Therapy, Medication Adherence. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND Patients with acute ischemic stroke receiving intravenous thrombolysis require intensive secondary prevention; however, poor medication adherence and inadequate lipid control in real-world practice often compromise long-term outcomes. This study evaluated the effects of a clinical pharmacist-led medication management program on medication adherence, lipid control, and functional outcomes in patients with acute ischemic stroke receiving intravenous thrombolysis. MATERIAL AND METHODS We retrospectively analyzed data from a prospective stroke database collected between January and October 2023. Patients treated with intravenous thrombolysis were assigned to either a control group or a pharmacist-led intervention group. Outcomes included 1-month lipid profiles and low-density lipoprotein cholesterol (LDL-C) reduction, and 3-month medication adherence and clinical outcomes. RESULTS A total of 190 patients were included (93 control, 97 intervention). Baseline characteristics, including statin use and length of hospital stay, were comparable. At 1 month, the intervention group had lower LDL-C levels than the control group (2.11 [1.64-2.53] vs 2.33 [1.80-2.96] mmol/L; P=0.037) and a greater reduction from baseline (0.98 [0.38-1.46] vs 0.70 [0.22-1.31] mmol/L; P=0.044). Multivariate analysis confirmed the pharmacist-led intervention as an independent predictor of greater LDL-C reduction (ß=0.239 mmol/L; P=0.016). Medication adherence at 3 months was higher in the intervention group and independently associated with optimal adherence (adjusted OR, 3.03; 95% CI, 1.53-5.99; P=0.001). Functional outcomes did not differ significantly. CONCLUSIONS Clinical pharmacist-led medication management was associated with improved medication adherence and early lipid control in patients with acute ischemic stroke receiving intravenous thrombolysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Jingjiang People's Hospital Affiliated to Yangzhou University, Jingjiang, Jiangsu, China.
- Department of Neurology, Jingjiang People's Hospital Affiliated to Yangzhou University, Jingjiang, Jiangsu, China.
- Pharmacy Management Section, Jingjiang People's Hospital Affiliated to Yangzhou University, Jingjiang, Jiangsu, China.
ORCID-Profile: Jiali Niu, Guangyu Zhao
Zitieren
APA
Niu, J., Ding, Y., Xue, T., Liu, Y., Gu, H., & Zhao, G. (2026). Effects of Clinical Pharmacist-Led Medication Management on Medication Adherence and Quality of Life in Stroke Patients Undergoing Intravenous Thrombolysis. Medical Science Monitor. https://doi.org/10.12659/msm.952042
Vancouver
Niu J, Ding Y, Xue T, Liu Y, Gu H, Zhao G. Effects of Clinical Pharmacist-Led Medication Management on Medication Adherence and Quality of Life in Stroke Patients Undergoing Intravenous Thrombolysis. Medical Science Monitor. 2026. doi:10.12659/msm.952042
BibTeX
@article{Niu2026,
author = {Niu, Jiali and Ding, Yunlong and Xue, Ting and Liu, Yin and Gu, Hong and Zhao, Guangyu},
title = {Effects of Clinical Pharmacist-Led Medication Management on Medication Adherence and Quality of Life in Stroke Patients Undergoing Intravenous Thrombolysis},
journal = {Medical Science Monitor},
year = {2026},
doi = {10.12659/msm.952042}
}
EUVIMED